UFH is the Most Used Anticoagulant in Hemodialysis, Decreasing the Risk of Clot Formation in the Circuit.

PHASE3CompletedINTERVENTIONAL

Enrollment

128

Participants

Timeline

Start Date

August 1, 2007

Primary Completion Date

December 1, 2008

Study Completion Date

December 1, 2008

Conditions

Hemodialysis Complication

Interventions

DRUG

Liquaemin

The standardized dose for the study was 150UI / kg heparin. It was administered directly through the dialysis equipment.

DRUG

Heptar

The standardized dose for the study was 150UI / kg heparin. It was administered directly through the dialysis equipment.